StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Do I see .96

<< Previous

Bullboard Posts

Next >>

Comment by Northerencentson Jan 14, 2021 8:40am

238 Views

Post# 32292565

RE:RE:Do I see .96

Yes I've said many times before our valuation is ridiculously low we are trading close to a 60 million cap after yesterday..with our current revenues we should be conservatively valued at 2-300 million

Aristotle on the other hand is minimum a billion dollar price tag

some r & d pysc companies are getting a billion placed on them in the words of that guy if Aristotle can't get that I'll eat my own sh*^

300 million cap price target =$5
1 billion cap price target=$16.6

c'mon let's get it !

<< Previous

Bullboard Posts

Next >>

Options trading in a volatile macro environment